Group 1 - The core point of the article is that Smoore International (06969) experienced a decline of over 4% in its stock price due to the announcement by the Ministry of Finance and the State Taxation Administration to cancel the export tax rebate for e-cigarette products starting from April 1, 2026, which will significantly impact profit margins [1] - The previous 13% tax rebate was crucial for companies to hedge costs and maintain international pricing advantages, and its removal means companies will have to bear the full VAT cost [1] - Zheshang Securities recently published a report indicating that the government is intensifying efforts to regulate illegal activities in the domestic e-cigarette production, sales, and export sectors, suggesting that the supply-side landscape of the industry will change [1] Group 2 - The report suggests that smaller illegal producers may be accelerated out of the market, which could benefit compliant companies like Smoore International, positioning it as a leading player in the industry [1]

Group 1 - The core point of the article highlights that Smoore International (06969) experienced a decline of over 4%, trading at HKD 11.18 with a transaction volume of HKD 172 million [1] - The Ministry of Finance and the State Taxation Administration announced that starting from April 1, 2026, the export tax rebate for electronic cigarette products will be canceled, which previously had a rebate rate of 13% [1] - The removal of the tax rebate means that companies will have to bear the full VAT cost, which will directly compress profit margins [1] Group 2 - Zheshang Securities (601878) released a report indicating that the government is intensifying efforts to regulate illegal activities in the domestic electronic cigarette production, sales, and export sectors [1] - The industry supply-side structure is expected to change, with illegal small workshops likely to be accelerated in their exit from the market [1] - As a compliant listed leader, Smoore International is expected to benefit from these regulatory changes [1]

Group 1 - The core point of the article highlights a significant decline in the stock price of Smoore International (06969), which dropped nearly 7% during trading and is currently down 3.31% at HKD 11.4, with a trading volume of HKD 132 million [1] - The Chinese Ministry of Finance and the State Taxation Administration announced a new export tax rebate adjustment, which will exclude nicotine-containing non-combustible products from the rebate starting April 1, 2026 [1] - Analysts indicate that the previous 13% tax rebate was crucial for companies to offset costs and maintain international pricing advantages; the removal of this rebate means companies will have to bear the full VAT cost, directly compressing profit margins [1] Group 2 - Huafu Securities released a research report suggesting that with international tobacco leaders' HNB products entering mainstream markets, Smoore's new tobacco products in new regions are expected to contribute incremental sales [1] - The report also notes that regions like the UK and other European areas are likely to shift towards more profitable products such as cartridge-based and open-system devices [1] - There is a significant increase in enforcement of regulations on e-cigarettes in the US, which is expected to restore market share for compliant products [1]

Group 1 - The core viewpoint of the article highlights the significant impact of the Chinese government's announcement to remove export tax rebates for nicotine-containing non-combustible products, effective from April 1, 2026, which is expected to compress profit margins for companies like Smoore International [1] - Smoore International's stock experienced a decline of nearly 7% during trading, closing down 3.31% at HKD 11.4, with a trading volume of HKD 132 million [1] - The previous 13% tax rebate was crucial for companies to offset costs and maintain international pricing advantages; the removal of this rebate means companies will have to bear the full value-added tax costs [1] Group 2 - Huafu Securities released a report indicating that the entry of international tobacco leaders' HNB products into mainstream markets could lead to increased sales of Smoore's new tobacco products in new regions [1] - There is potential for stronger profitability in regions like the UK and other European areas, particularly with the shift towards more profitable pod-based and open-system products [1] - The enforcement of regulations on e-cigarettes in the US has intensified, suggesting a significant recovery potential for compliant product shares in the market [1]

Summary of the Conference Call for Smoore International Company Overview - Smoore International is transitioning from an electronic vapor company to a platform company focused on heated not-burn (HNB) technology, collaborating with firms like British American Tobacco to advance new tobacco products in response to the declining traditional cigarette market [2][5]. Industry Trends - The global traditional cigarette market is experiencing a continuous decline, with a significant drop in per capita smoking rates in the U.S. by 30% to 40% since 1970. The smoking population and consumption have decreased by approximately 1% annually over the past 20 years [7]. - New tobacco products, including HNB and oral products, are seen as key to overcoming the challenges faced by traditional tobacco companies. HNB and oral products are more suitable for large traditional tobacco firms, while the vapor electronic cigarette market is dominated by Chinese manufacturers [10]. Key Points on Smoore's Business - Smoore's HNB products are gaining market share in Japan, Italy, and Poland, indicating strong market performance and growth potential. For instance, Japan saw a 1.4% increase in market share within three months [11]. - The market valuation of Smoore is considered conservative, with future growth expected primarily from HNB business expansion. Achieving sales of over 10 billion units by 2026 could lead to a significant leap in performance [13]. - Smoore's U.S. subsidiary is focused on the medical vaporization sector and has applied for FDA certification, investing approximately 400 million yuan annually in R&D. This segment is expected to become a new growth point within three years [19]. Financial Projections and Market Expectations - Smoore has set ambitious market capitalization targets of 300 billion, 400 billion, and 500 billion yuan by 2025, despite its current valuation being in the hundreds of billions [4]. - The traditional electronic vapor market is stabilizing, with an expected annual growth rate of over 10% [3][18]. - The company anticipates that its HNB business could contribute significantly to its valuation, with estimates suggesting a sales share of 10-15% from HNB products, potentially leading to substantial profit elasticity [16][17]. Future Outlook - The domestic new tobacco market in China is expected to grow significantly, with Smoore positioned to benefit from this shift. The potential transition towards new tobacco products in China could create vast market opportunities [14]. - The medical vaporization segment is seen as a third growth curve for Smoore, with expectations for commercialization and revenue generation within three years [19][20]. Conclusion - Smoore International is strategically positioned to capitalize on the evolving tobacco landscape, with a focus on HNB technology and medical applications. The company's growth potential is supported by its innovative R&D efforts and collaborations with major tobacco firms, setting the stage for a promising future in the new tobacco market.

FF301 呈交日期: 2026年1月7日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06969 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | 10,000,000,000 | USD | | 0.01 | USD | | 100,000,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | 10,000,000,000 | USD | | 0.01 | USD | | 100,000,000 | 本月底法定/註冊股本總額： USD 100,000,000 第 1 頁 共 10 頁 v 1.1.1 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態 ...

Core Viewpoint - Smoore International, known as the "first stock of electronic cigarettes," is facing significant challenges, including a declining stock price and market value, attributed to regulatory pressures, stagnant profits despite revenue growth, and changing market sentiment [1][6][25] Financial Performance - In Q3 2025, Smoore's revenue reached 10.21 billion RMB, a year-on-year increase of 21.8%, with Q3 revenue hitting a record high of 4.197 billion RMB, growing over 27% year-on-year and quarter-on-quarter [4] - However, net profit for the first three quarters of 2025 was 809 million RMB, down 23.8% year-on-year, with a Q3 net profit of 317 million RMB, a decrease of 16.4% [4] - The company's net profit margin has plummeted from 38.44% in 2021 to 7.92% in the first three quarters of 2025 [4] Market Challenges - Smoore's revenue from mainland China dropped by 92.7% in 2023 due to stringent regulations, with its revenue share falling from approximately 18.5% to about 1.5% [6] - Increased sales and distribution expenses, which rose by 31.2% to 491 million RMB in the first half of 2025, have further pressured profitability [6] - The company's gross margin has decreased from 53.6% in 2021 to 37.3% in the first half of 2025, indicating a decline in the quality of revenue growth [7] Strategic Shift - Smoore is attempting to diversify its business by launching the "Lanzhi" beauty brand, which utilizes TPS (Transdermal Permeation System) technology, aiming to create a "second growth curve" [1][13] - The Lanzhi brand generated sales of 30.61 million RMB in the first half of 2025, but its contribution to overall revenue remains minimal [12][23] - The beauty market is seen as a high-margin opportunity, with Smoore hoping to replicate its electronic cigarette success in this new sector [13] Competitive Landscape - The beauty device market is highly competitive, with established international brands dominating the high-end segment and local brands capturing the mid-to-low end [16] - Lanzhi faces challenges such as low brand recognition, insufficient distribution channels, and competition from other beauty companies [16][24] - The effectiveness and safety of the TPS technology remain under scrutiny, with concerns about its ability to deliver active ingredients effectively and safely [18][19] Regulatory Environment - The regulatory landscape for beauty aerosol products is still evolving, with uncertainties regarding specific regulations for aerosol beauty technology [21] - Smoore's transition into the beauty sector may not provide immediate relief from its current profitability issues, as the Lanzhi brand's profitability may take up to two years to materialize [23][25]

Group 1 - The company, Smoore International (06969), announced the grant of a total of 915,000 share options to five eligible participants under the revised share option plan approved by shareholders on February 18, 2025 [1] - Each grantee is required to pay HKD 1 as the consideration for accepting the grant of share options within a period determined by the board, not exceeding 30 days from the grant date [1]

Group 1 - The core announcement is that Smoore International (06969) has granted a total of 915,000 stock options to five eligible participants under a revised stock option plan approved by shareholders on February 18, 2025 [1] - Each participant must pay HKD 1 as the consideration for accepting the stock options within a period determined by the board, not exceeding 30 days from the grant date [1]

Group 1 - The core announcement is that Smoore International (06969) has granted a total of 545,000 share awards to seven eligible participants under the revised share award plan, pending acceptance by the recipients [1]